Marc D. Kozin

Insider Reports History

Signature
Patrick J. Kinney, Jr. as attorney-in-fact for Marc D. Kozin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Marc D. Kozin:

Form 4 holding Director

Vascular Biogenics Ltd.

Security class
Ordinary Shares
Shares / value
39,000
Estimated value
Report date
01 Jan 2023
Price
Ownership
By Marc D. Kozin Irrevocable Trust
Form 4 holding Director

UFP TECHNOLOGIES INC

Security class
Stock Option (Right to Buy)
Shares / value
493
Estimated value
Report date
05 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock, $.01 Par Value
Underlying amount
Form 4 holding Director

CHIMERIX INC

Security class
Employee Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
21 Apr 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Dicerna Pharmaceuticals Inc

Security class
Common Stock
Shares / value
0
Estimated value
Report date
28 Dec 2021
Price
$38.25
Ownership
By Marc D. Kozin Revocable Trust
Form 4 holding Director

Dicerna Pharmaceuticals Inc

Security class
Director Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
28 Dec 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Dicerna Pharmaceuticals Inc

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
28 Dec 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Marc D. Kozin

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .